Abstract
Obesity and pain are common problems affecting the older adult and a possible relationship between the two is considered. Obesity and pain themselves are significant burdens on the individual, the healthcare system, and society as a whole and they can lead to emotional conditions such as stress, anxiety, and depression – which lead to further healthcare utilization and burden. Cross-sectional studies have revealed a high correlation between pain and obesity and a few longitudinal studies implicate obesity as a risk factor for the development of pain and the associated reduction in quality of life. Obesity leads to pain due to mechanical stress and metabolic disruptions, so mitigating obesity may help reduce the risk of developing pain and improve recovery from pain. More research is warranted to elucidate the mechanistic links between obesity and pain and to determine the optimal treatment strategies for reducing these comorbities. Reducing obesity could reduce pain medication burden.
Keywords: Chronic pain, obesity, quality of life, osteoarthritis, fibromyalgia, inflammation.
Current Pharmaceutical Design
Title:Pain and Obesity in the Older Adult
Volume: 20 Issue: 38
Author(s): Robert Taylor Jr., Joseph V. Pergolizzi Jr., Robert B. Raffa, Srinivas Nalamachu and Philip J. Balestrieri
Affiliation:
Keywords: Chronic pain, obesity, quality of life, osteoarthritis, fibromyalgia, inflammation.
Abstract: Obesity and pain are common problems affecting the older adult and a possible relationship between the two is considered. Obesity and pain themselves are significant burdens on the individual, the healthcare system, and society as a whole and they can lead to emotional conditions such as stress, anxiety, and depression – which lead to further healthcare utilization and burden. Cross-sectional studies have revealed a high correlation between pain and obesity and a few longitudinal studies implicate obesity as a risk factor for the development of pain and the associated reduction in quality of life. Obesity leads to pain due to mechanical stress and metabolic disruptions, so mitigating obesity may help reduce the risk of developing pain and improve recovery from pain. More research is warranted to elucidate the mechanistic links between obesity and pain and to determine the optimal treatment strategies for reducing these comorbities. Reducing obesity could reduce pain medication burden.
Export Options
About this article
Cite this article as:
Jr. Taylor Robert, Jr. V. Pergolizzi Joseph, Raffa B. Robert, Nalamachu Srinivas and Balestrieri J. Philip, Pain and Obesity in the Older Adult, Current Pharmaceutical Design 2014; 20 (38) . https://dx.doi.org/10.2174/1381612820666140316131431
DOI https://dx.doi.org/10.2174/1381612820666140316131431 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cellular Signaling Crosstalk Between Multiple Receptors for Investigation of Pathophysiology in Multifactorial Diseases - What is Clinically-Relevant Crosstalk?
Current Medicinal Chemistry The Unaddressed Issue of Optimal Antithrombotic Treatment after Coronary Artery Stenting in Patients with an Indication for Anticoagulation: Current Evidence and Suggested Practice
Vascular Disease Prevention (Discontinued) Cholesterol Oxidation Products and Disease: An Emerging Topic of Interest in Medicinal Chemistry
Current Medicinal Chemistry Autoimmune (Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA) – Animal Models as a Proof of Concept
Current Medicinal Chemistry Aerobic Exercise Does Not Predict Brain Derived Neurotrophic Factor And Cortisol Alterations in Depressed Patients
CNS & Neurological Disorders - Drug Targets Vaccines for Patients with COPD
Recent Patents on Inflammation & Allergy Drug Discovery Pathophysiology of Idiopathic Atrial Fibrillation - Prognostic and Treatment Implications
Current Pharmaceutical Design The Coronary Circulation in Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Moderate Wine Consumption in the Prevention of Metabolic Syndrome and its Related Medical Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets Preface
Current Drug Targets - Infectious Disorders Protecting the Heart: Biological Targets and Clinical Strategies
Current Pharmaceutical Design Insights into Oxidative Stress: The Isoprostanes
Current Medicinal Chemistry Pleiotropic Effects of Fenofibrate
Current Pharmaceutical Design Ghrelin as a Neuroprotective and Palliative Agent in Alzheimer's and Parkinson's Disease
Current Pharmaceutical Design Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer
Current Drug Targets Imaging Neuroinflammation in Ischemic Stroke and in the Atherosclerotic Vascular Disease
Current Vascular Pharmacology Human Milk has Anti-Oxidant Properties to Protect Premature Infants
Current Pediatric Reviews HIV Infection and Myocardial Infarction
Current HIV Research Long-Term Bronchodilator Inhaled Therapy in COPD: The Role of Tiotropium Bromidum
Reviews on Recent Clinical Trials